R C M Technologies Inc

R C M Technologies Inc(RCMT)股票分析

$34.890

+0.031 (+0.09%)收盤時

Loading chart…
最高
35.615
開盤
35.330
成交量加權均價
35.07
成交量
43.35K
市值
142.82M
最低
34.705
成交金額
1.52M
企業價值/稅息折舊攤銷前利潤(TTM)
7.14

RCM Technologies, Inc. is a provider of business and technology solutions through the deployment of specialty healthcare, engineering, life sciences, information technology services, data management and solutions. The Company's segments include Specialty Health Care, Engineering, and Life Sciences, Data and Solutions (LS&D). The Specialty Health Care segment provides staffing solutions including medical healthcare professionals, health information management professionals, nurses, paraprofessionals, physicians, and therapists. The Engineering segment provides a comprehensive portfolio of engineering and design services across three verticals: energy services, process and industrial, and aerospace. The LS&D segment provides enterprise business solutions, application development and support, information technology infrastructure deployment and management, and technology and business solutions for the Life Sciences industry and other specific verticals.

AI 分析 of R C M Technologies Inc (RCMT)

持有

RCM Technologies Inc is currently a hold. The stock is priced at $34.99, which is 67.1% of its 52-week range, indicating it is closer to the high end. The RSI is at 21.62, suggesting it is oversold, but the recent 20-day change of -15.87% indicates a downward trend. Additionally, the forward P/E of 12.80 suggests it is undervalued compared to its earnings potential, but the upcoming earnings report on November 4 could be a risk factor if results do not meet expectations.

分析師評級(1)

-8.28% 下跌空間
買進
1 買進
0 持有
0 賣出
目前: 34.89
最低
32.00
平均
32.00
最高
32.00

Benchmark

2026-04-08

目標價

$36

買進

Benchmark

2025-03-21

目標價

$30

強烈買進

Benchmark

2024-11-11

目標價

$37

強烈買進

B. Riley Securities

2024-11-11

目標價

$37

強烈買進

Benchmark

2024-08-13

目標價

$33

強烈買進

估值指標

R C M Technologies Inc(RCMT)目前預期本益比為 16.18,5 年平均預期本益比為 9.54。

預期本益比

嚴重高估
5 年均值 P/E
9.54
目前P/E
16.18
高估
12.46
低估
6.63

預期 EV/EBITDA

合理
5 年均值 EV/EBITDA
6.38
目前EV/EBITDA
7.14
高估
7.79
低估
4.98

預期股價營收比

合理
5 年均值 P/S
0.53
目前P/S
0.64
高估
0.65
低估
0.40

Alphio AI 對 RCMT 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%RCMT

$26.08

情境價格

基

基準

基準 · 50%RCMT

$21.24

情境價格

悲

悲觀

悲觀 · 25%RCMT

$18.77

情境價格

事件時間軸

2026-05-15 (ET)

13:20:00

RCM Technologies Q1 Earnings Decline, Shares Down Nearly 19%

2025-07-01 (ET)

08:44:35

RCM Technologies added to Russell 3000, small-cap Russell 2000 Indexes

2025-03-12 (ET)

16:16:59

RCM Technologies reports Q4 EPS 49c, vs. 73c last year

2025-02-25 (ET)

07:48:00

RCM Technologies launches RCM HCM's program to resell UKG Ready suite

2024-12-23 (ET)

07:30:05

Twelve option delistings on December 23rd

資訊

RCMT 常見問題 —— 由 Alphio AI 解答

RCM Technologies, Inc. is a provider of business and technology solutions through the deployment of specialty healthcare, engineering, life sciences, information technology services, data management and solutions. The Company's segments include Specialty Health Care, Engineering, and Life Sciences, Data and Solutions (LS&D). The Specialty Health Care segment provides staffing solutions including medical healthcare professionals, health information management professionals, nurses, paraprofessionals, physicians, and therapists. The Engineering segment provides a comprehensive portfolio of engineering and design services across three verticals: energy services, process and industrial, and aerospace. The LS&D segment provides enterprise business solutions, application development and support, information technology infrastructure deployment and management, and technology and business solutions for the Life Sciences industry and other specific verticals. It operates in the Industrials sector (SERVICES-HELP SUPPLY SERVICES industry).

RCM Technologies Inc is currently a hold. The stock is priced at $34.99, which is 67.1% of its 52-week range, indicating it is closer to the high end. The RSI is at 21.62, suggesting it is oversold, but the recent 20-day change of -15.87% indicates a downward trend. Additionally, the forward P/E of 12.80 suggests it is undervalued compared to its earnings potential, but the upcoming earnings report on November 4 could be a risk factor if results do not meet expectations.

1 analysts cover RCMT: 1 rate it Buy, 0 Hold and 0 Sell. The average price target is 32.00.

暫無貼文

註冊或登入後參與討論

相關文章

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易